NCT04447703 2025-12-02
Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study
Thomas Jefferson University
Phase NA Completed
Thomas Jefferson University
Abramson Cancer Center at Penn Medicine
Mayo Clinic
Children's Oncology Group